Elucid Bioimaging's vascuCAP artificial intelligence (AI) software has been added to the IBM Imaging AI Marketplace.
vascuCAP analyzes CT angiograms to characterize plaque tissues in a manner that could previously only be done with a tissue specimen, Elucid said. It provides objective quantification of atherosclerotic plaque for the coronary, carotid, aorta, and femoral arteries, according to the company.
